Certified by Founder Lodge
Acorn Bioventures
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $108,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We invest in and partner with private and small capitalization biotech, specialty pharma and medical device companies.
| Company | Date | Round | Raised |
|---|---|---|---|
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Neuron23 |
June, 26 ,2025 | Series D | $96,500,000 |
Bicara Therapeutics
Neuron23
dezerv.
FalconX
Kristal.AI
Finary
Savart
XCENA | $135,000,000 | (Jun 2, 2026)
Voxmind | $735,203 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)